Evidence map›Paper›PMID 25176133›Full record

ArticleBritish journal of pharmacology2015

Auto-inhibition at a ligand-gated ion channel: a cross-talk between orthosteric and allosteric sites.

Xiang-Qun Hu

Open access · bronzeAbstract read
In one paragraph

Article in British journal of pharmacology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Xiang-Qun HuDepartment of Biomedical Sciences, College of Health Sciences, Marquette University, Milwaukee, WI, USA.
Marquette University · US

Funding

Alcohol Actions on NMDA Receptor Gating DomainsR01AA015203 · NIAAA · MARQUETTE UNIVERSITY · PI PEOPLES, ROBERT WILLIAM · 2005 to 2015
$2.6M
NIAAA NIH HHS AA015203-01A1NIAAA NIH HHS R01 AA015203
6 · The paper itself

Abstract

background and purposeA ligand is believed to produce either positive or negative responses, or to block both of them. However, an indole compound was found to promote both positive and negative effects at the 5-HT3 AB receptor, which displays a low level of spontaneous activity. The present study attempted to delineate the mechanisms underlying this phenomenon. EXPERIMENTAL APPROACH: The spontaneously active V291S 5-HT3 A receptor was used to explore the properties of 5-hydroxyindole (5-HoI) and 5-methoxyindole (5-MoI), structural analogues of 5-HT, either alone or in combination with orthosteric probes. KEY

resultsTwo types of efficacy switching were initiated by altering ligand structure and concentration. At lower concentrations, a subtle structural change at position 5 of the indole molecule resulted in opposite effects. 5-HoI apparently elicited partial allosteric inverse agonism, whereas 5-MoI induced allosteric agonism. Interestingly, at a higher concentration, these indoles produced distinct auto-inhibition, manifested as a switch from positive to negative effects. 5-HoI induced a transition from orthosteric agonism to allosteric inverse agonism, whereas 5-MoI produced a shift from allosteric agonism to orthosteric inverse agonism. The auto-inhibition appears to involve communication between orthosteric and allosteric sites of the active receptor conformation and/or between inactive and active conformations. An additive effect of orthosteric and allosteric inverse agonism and insensitivity of allosteric agonism to orthosteric antagonism were also demonstrated. CONCLUSIONS AND IMPLICATIONS: Together, the results suggest that the moiety at position 5 of the indole structure is a critical determinant of a ligand's properties at the 5-HT3 A receptor, providing new insights into understanding ligand-receptor interactions.

Indexed as

Allosteric SiteHEK293 CellsHumansIndolesReceptors, Serotonin, 5-HT3Serotonin 5-HT3 Receptor AgonistsSerotonin 5-HT3 Receptor Antagonists5-hydroxyindole5-methoxyindoleIndolesReceptors, Serotonin, 5-HT3Serotonin 5-HT3 Receptor AgonistsSerotonin 5-HT3 Receptor Antagonists

Identifiers

PMID25176133
PMCPMC4280970
OpenAlexW1818958458

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.